Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.6 (
thromboplastin
)
13,278
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Design of blood compatible surfaces is obligatory to minimize platelet surface interactions and improve the thromboresistance of foreign surfaces when they are utilized as biomaterials particularly for blood contacting devices. Pure metallocene polyethylene (mPE) and nitric acid (
HNO3
) treated mPE antithrombogenicity and hydrophilicity were investigated. The contact angle of the mPE treated with
HNO3
decreased. Surface of mPE and
HNO3
treated mPE investigated with FTIR revealed no major changes in its functional groups. 3D Hirox digital microscopy, SEM and AFM images show increased porosity and surface roughness. Blood coagulation assays prothrombin time (PT) and activated partial
thromboplastin
time (APTT) were delayed significantly (P < 0.05) for
HNO3
treated mPE. Hemolysis assay and platelet adhesion of the treated surface resulted in the lysis of red blood cells and platelet adherence, respectively indicating improved hemocompatibility of
HNO3
treated mPE. To determine that
HNO3
does not deteriorate elastic modulus of mPE, the elastic modulus of mPE and
HNO3
treated mPE was compared and the result shows no significant difference. Hence, the overall observation suggests that the novel
HNO3
treated mPE may hold great promises to be exploited for blood contacting devices like grafts, catheters, and etc.
...
PMID:Unravelling the potential of nitric acid as a surface modifier for improving the hemocompatibility of metallocene polyethylene for blood contacting devices. 2681 37